Not Tagged
bms
['cll', 'leukemia', 'scienceatbms', 'bms']
patients with relapsed or refractory chronic lymphocytic leukemia (#cll), after receiving prior therapies, currently have no standard of care and limited treatment options. we are committed to expanding research efforts to bring innovative treatments for patients. #asco23
Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below: